dipyridamole has been researched along with Staphylococcal Infections in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Staphylococcal Infections: Infections with bacteria of the genus STAPHYLOCOCCUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martin, NK | 1 |
| Domínguez-Robles, J | 1 |
| Stewart, SA | 1 |
| Cornelius, VA | 1 |
| Anjani, QK | 1 |
| Utomo, E | 1 |
| García-Romero, I | 1 |
| Donnelly, RF | 1 |
| Margariti, A | 1 |
| Lamprou, DA | 1 |
| Larrañeta, E | 1 |
1 other study available for dipyridamole and Staphylococcal Infections
| Article | Year |
|---|---|
Fused deposition modelling for the development of drug loaded cardiovascular prosthesis.
Topics: Anti-Bacterial Agents; Blood Cells; Blood Vessel Prosthesis; Delayed-Action Preparations; Dipyridamo | 2021 |